Psychological Interventions to Prevent Late Effects in Breast Cancer (PREVENT)
Primary Purpose
Pain, Postoperative, Fatigue, Breast Cancer
Status
Recruiting
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Medical hypnosis
Internet-based Acceptance and Commitment Therapy (iACT)
Mindfulness session
Treatment as Usual (TAU)
Sponsored by
About this trial
This is an interventional prevention trial for Pain, Postoperative focused on measuring Breast cancer, Post-surgical pain, Fatigue, Hypnosis, Acceptance and commitment therapy
Eligibility Criteria
Inclusion Criteria:
- Women diagnosed with breast cancer and scheduled for surgery
- Be able to provide informed consent
Exclusion Criteria:
- Insufficient Norwegian speaking or writing skills to participate in the interventions and fill out questionnaires
- Cognitive and psychiatric impairment
- Other serious malignancies
Sites / Locations
- Oslo University Hospital (Aker Hospital)Recruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Hypnosis + iACT
Mindfulness + treatment as usual (TAU)
Arm Description
Single 20 minute medical hypnosis session delivered pre-surgery plus internet-based acceptance and commitment therapy delivered post-surgery
Single 20 minute mindfulness session delivered pre-surgery plus treatment as usual post-surgery
Outcomes
Primary Outcome Measures
Chronic post-surgical pain
Measured through a Numeric Rating Scale (NRS) for pain intensity. The scale ranges from 0-10, anchored by verbal descriptors at either end of the scale where 0 is no pain at all and 10 is the worst possible pain.
Post-surgical fatigue
Measured through the 13-item Functional Assessment of Chronic Illness Therapy-Fatigue subscale (FACIT-F) which is a unidimensional self-report scale to assess fatigue and its impact on daily life. The score range is 0-52 where a higher score indicates better quality of life (i.e. less symptoms and disability)
Secondary Outcome Measures
Pain intensity, pain unpleasantness, fatigue, nausea, physical discomfort and emotional upset
Measured by a Visual Analogue Scale (VAS) (to replicate a previous hypnosis trial - Montgomery et al 2007). The range is 0-100 where a higher score indicates more intense symptoms.
Stress (immunological) reactivity
Immune function is assessed through whole blood samples using the standardized TruCulture system that contains immunogenic stimuli (infected tubes). This test will reveal the induced innate and adaptive immune response in whole blood after stimulation with LPS, by quantifying the release of soluble immune activation products (cytokines, chemokines, soluble receptors etc.) in the supernatant and by measuring the transcription level (mRNA) in the circulating blood (immune) cells.
Number of psychotropic and pain-related prescriptions
Usage of psychotropic and pain medication obtained through registry data from the Norwegian Prescription Database at 3 and 12 months follow-up. Number of prescriptions will be summarized and compared between intervention and control group.
Number of sick leave days
Days away from work on sick leave will be measured through registry data
Psychological flexibility
Measured through the Acceptance and Action Questionnaire (AAQ-II). The scale ranges from 7-49, where higher score indicates more psychological inflexibility
Psychological distress
Measured through the Hospital Anxiety and Depression Scale (HADS). The total score ranges from 0-42, where a higher score indicates more symptoms
Full Information
NCT ID
NCT04518085
First Posted
August 5, 2020
Last Updated
May 18, 2022
Sponsor
University of Oslo
Collaborators
Oslo University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04518085
Brief Title
Psychological Interventions to Prevent Late Effects in Breast Cancer
Acronym
PREVENT
Official Title
Pre- and Post-operative Psychological Interventions to Prevent Pain and Fatigue After Breast Cancer Surgery: a Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 1, 2020 (Actual)
Primary Completion Date
March 3, 2022 (Actual)
Study Completion Date
January 1, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Oslo
Collaborators
Oslo University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The study aims to investigate whether a combined pre-operative medical hypnosis plus a post-operative internet-based acceptance and commitment intervention are more effective in preventing post-surgical pain and fatigue following breast cancer surgery compared with pre-operative mindfulness plus treatment as usual.
Detailed Description
The trial will include 200 patients undergoing breast cancer surgery at Oslo University Hospital. The patients will be randomized into two groups. One group will receive a 20 minute pre-surgical hypnosis session delivered by an experienced clinical psychologist plus a post-surgical internet-based acceptance and commitment intervention. The control group will receive a 20 minute pre-surgical mindfulness session delivered through an audio recording plus treatment as usual. The primary outcomes of the study are quantitative measures of post-surgical pain and fatigue. In addition, relationships between biomarkers of stress and subacute post-surgical pain and fatigue will be analyzed using using blood- and hair samples. The study uses a longitudinal design with baseline measures obtained pre-surgery and follow up measures obtained 3 and 12 months post-surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Postoperative, Fatigue, Breast Cancer
Keywords
Breast cancer, Post-surgical pain, Fatigue, Hypnosis, Acceptance and commitment therapy
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Controlled Trial, in which participants are randomly allocated to either the intervention group or an active control group.
Masking
InvestigatorOutcomes Assessor
Masking Description
The intervention group vs. active control group status will be known to the participants and the health care personnel delivering the interventions. However, the investigator, outcome assessor and the additional health care personnel at the unit will be masked to the conditions.
Allocation
Randomized
Enrollment
200 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Hypnosis + iACT
Arm Type
Experimental
Arm Description
Single 20 minute medical hypnosis session delivered pre-surgery plus internet-based acceptance and commitment therapy delivered post-surgery
Arm Title
Mindfulness + treatment as usual (TAU)
Arm Type
Active Comparator
Arm Description
Single 20 minute mindfulness session delivered pre-surgery plus treatment as usual post-surgery
Intervention Type
Behavioral
Intervention Name(s)
Medical hypnosis
Intervention Description
Single session 20 minutes hypnosis session originally developed and tested by Montgomery et al. (2007) in a similar setting. Delivered by an experienced clinical psychologist.
Intervention Type
Behavioral
Intervention Name(s)
Internet-based Acceptance and Commitment Therapy (iACT)
Intervention Description
Access to an online platform developed to this study containing video clips and audio files with ACT consistent material
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness session
Intervention Description
Single session mindfulness session delivered by audio file
Intervention Type
Behavioral
Intervention Name(s)
Treatment as Usual (TAU)
Intervention Description
Treatment as usual as part of post-surical care
Primary Outcome Measure Information:
Title
Chronic post-surgical pain
Description
Measured through a Numeric Rating Scale (NRS) for pain intensity. The scale ranges from 0-10, anchored by verbal descriptors at either end of the scale where 0 is no pain at all and 10 is the worst possible pain.
Time Frame
3 months after surgery
Title
Post-surgical fatigue
Description
Measured through the 13-item Functional Assessment of Chronic Illness Therapy-Fatigue subscale (FACIT-F) which is a unidimensional self-report scale to assess fatigue and its impact on daily life. The score range is 0-52 where a higher score indicates better quality of life (i.e. less symptoms and disability)
Time Frame
3 months after surgery
Secondary Outcome Measure Information:
Title
Pain intensity, pain unpleasantness, fatigue, nausea, physical discomfort and emotional upset
Description
Measured by a Visual Analogue Scale (VAS) (to replicate a previous hypnosis trial - Montgomery et al 2007). The range is 0-100 where a higher score indicates more intense symptoms.
Time Frame
On the day of surgery right before discharge
Title
Stress (immunological) reactivity
Description
Immune function is assessed through whole blood samples using the standardized TruCulture system that contains immunogenic stimuli (infected tubes). This test will reveal the induced innate and adaptive immune response in whole blood after stimulation with LPS, by quantifying the release of soluble immune activation products (cytokines, chemokines, soluble receptors etc.) in the supernatant and by measuring the transcription level (mRNA) in the circulating blood (immune) cells.
Time Frame
Baseline (pre-surgery) plus 4 weeks post-surgery (Cortisol will only be measured at baseline)
Title
Number of psychotropic and pain-related prescriptions
Description
Usage of psychotropic and pain medication obtained through registry data from the Norwegian Prescription Database at 3 and 12 months follow-up. Number of prescriptions will be summarized and compared between intervention and control group.
Time Frame
3 and 12 months post-surgery
Title
Number of sick leave days
Description
Days away from work on sick leave will be measured through registry data
Time Frame
3 and 12 months post-surgery
Title
Psychological flexibility
Description
Measured through the Acceptance and Action Questionnaire (AAQ-II). The scale ranges from 7-49, where higher score indicates more psychological inflexibility
Time Frame
3 and 12 months post-surgery
Title
Psychological distress
Description
Measured through the Hospital Anxiety and Depression Scale (HADS). The total score ranges from 0-42, where a higher score indicates more symptoms
Time Frame
3 and 12 months post-surgery
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Eligible participants are women (biological sex) diagnosed with breast cancer
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Women diagnosed with breast cancer and scheduled for surgery
Be able to provide informed consent
Exclusion Criteria:
Insufficient Norwegian speaking or writing skills to participate in the interventions and fill out questionnaires
Cognitive and psychiatric impairment
Other serious malignancies
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Silje E Reme, PhD
Phone
004722845236
Email
s.e.reme@psykologi.uio.no
First Name & Middle Initial & Last Name or Official Title & Degree
Henrik B Jacobsen, PhD
Email
h.b.jacobsen@psykologi.uio.no
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Silje E Reme, PhD
Organizational Affiliation
University of Oslo + Oslo University Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Henrik B Jacobsen, PhD
Organizational Affiliation
University of Oslo + Oslo University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Oslo University Hospital (Aker Hospital)
City
Oslo
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vibeke Schou Jensen, RN
Phone
22894181
Email
VIBJEN@ous-hf.no
First Name & Middle Initial & Last Name & Degree
May-Britt Svanevik, RN
Phone
22894181
Email
MAYSVA@ous-hf.no
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
The study protocol, along with the intervention protocols, will all be published and publicly available. Registry data will not be shared as this is not allowed to share according to Norwegian law. However, data files involving questionnaire and biomarker data will be made available upon reasonable request. Due to privacy concerns, the complete data files will not be shared online.
IPD Sharing Time Frame
The study protocol will be published as soon as possible. The intervention protocols will be publicly available upon study completion. Data files will be made available when the main analyses are completed, in 2025 at the latest.
IPD Sharing Access Criteria
Data files involving self-report data will be shared upon reasonable request when the main analyses are completed and published.
Citations:
PubMed Identifier
34818921
Citation
Lind SB, Jacobsen HB, Solbakken OA, Reme SE. Clinical Hypnosis in Medical Care: A Mixed-Method Feasibility Study. Integr Cancer Ther. 2021 Jan-Dec;20:15347354211058678. doi: 10.1177/15347354211058678.
Results Reference
background
PubMed Identifier
35802618
Citation
Reme SE, Munk A, Holter MTS, Falk RS, Jacobsen HB. Pre- and post-operative psychological interventions to prevent pain and fatigue after breast cancer surgery (PREVENT): Protocol for a randomized controlled trial. PLoS One. 2022 Jul 8;17(7):e0268606. doi: 10.1371/journal.pone.0268606. eCollection 2022.
Results Reference
derived
Links:
URL
https://www.sv.uio.no/psi/english/research/projects/pre-and-post-operative-psychological-interventions/index.html
Description
Project web page
Learn more about this trial
Psychological Interventions to Prevent Late Effects in Breast Cancer
We'll reach out to this number within 24 hrs